Correlation of carcinoembryonic antigen with prognosis of hepatocellular carcinoma after hepatectomy

Chinese Journal of Oncology

Volumn 36, Issue 6, 2014, Pages 430-434

  Zhao, Jianjun ^a   Yan, Too ^a   Bi, Xinyu ^a   Zhao, Hong ^a   Huang, Zhen ^a   Zhou, Jianguo ^a   Li, Zhiyu ^a   Li, Cong ^a   Cai, Jianqiang ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Carcinoembryonic antigen; Hepatectomy; Hepatocellular carcinoma; Prognosis; Survival rate

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PERFORATION; POST TREATMENT SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; CARCINOMA, HEPATOCELLULAR; KAPLAN MEIER METHOD; LIVER NEOPLASMS; METABOLISM; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE;

CARCINOEMBRYONIC ANTIGEN; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84927172347     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2014.06.006     Document Type: Article

References (12)

1. Fomer A, Llovet JM, Bruix J. Hepatocellular carcinoma [J]. Lancet, 2012, 379(9822):1245-1255.
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
3. Abelev GL, Perova SD, Khramkova NI, et al. Production of embryonal alpha-globulin by transplantable mouse hepatomas [J]. Transplantation, 1963, 1:174-180.
4. Chan SL, Chan AT, Yeo W. Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both? [J]. Future Oncol, 2009, 5(6):889-899.
5. Zhou J, Yan T, Bi X, et al. Evaluation of seven different staging systems for alpha-fetoprotein expression in hepatocellular carcinoma after hepatectomy [J]. Tumour Biol, 2013, 34(2):1061-1070.
6. Macnab GM, Urbanowicz JM, Kew MC. Carcinoembryonic antigen in hepatocellular cancer[J]. Br J Cancer, 1978, 38(1):51-54.
7. Yang XR, Xu Y, Yu B, et al. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma [J]. Gut, 2010, 59(7):953-962.
8. Yamashita T, Ji J, Budhu A, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features[J]. Gastroenterology, 2009, 136(3):1012-1024.
9. Song S, Hong JC, McDonnell SE, et al. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence [J]. Ann Surg Oncol, 2012, 19(8):2471-2476.
10. Lan YT, Lin JK, Lin TC, et al. Prognostic significance of perioperative change of CEA level in colorectal patients when pre-operative level is normal[J]. Hepatogastroenterology, 2012, 59(115):717-720.
11. Hanagiri T, Sugaya M, Takenaka M, et al. Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage 1 nonsmall cell lungcancer[J]. Lung Cancer, 2011, 74(1):112-117.
12. Kumar M, Zhao X, Wang XW. Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? [J]. Cell Biosci, 2011, 1(1):5.